APPLIED GENETIC TECHNOLOGIES CORP Quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD from Q2 2013 to Q2 2022

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
Applied Genetic Technologies Corp quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q2 2013 to Q2 2022.
  • Applied Genetic Technologies Corp Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending June 30, 2022 was $61.9M, a 40.2% increase year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2022 $61.9M +$17.7M +40.2% Jun 30, 2022 10-K 2022-09-27
Q2 2021 $44.1M +$14.1M +46.8% Jun 30, 2021 10-K 2022-09-27
Q2 2020 $30.1M +$9.55M +46.5% Jun 30, 2020 10-K 2021-09-23
Q2 2019 $20.5M +$6.62M +47.6% Jun 30, 2019 10-K 2020-09-18
Q2 2018 $13.9M +$4.79M +52.5% Jun 30, 2018 10-K 2019-09-26
Q2 2017 $9.12M -$18M -66.3% Jun 30, 2017 10-K 2018-09-11
Q2 2016 $27.1M -$1.46M -5.1% Jun 30, 2016 10-K 2017-09-13
Q2 2015 $28.6M +$5.9M +26% Jun 30, 2015 10-K/A 2017-09-08
Q2 2014 $22.7M +$4.62M +25.6% Jun 30, 2014 10-K 2015-09-10
Q2 2013 $18M Jun 30, 2013 10-K 2014-09-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.